ONC BeOne Medicines Ltd.
Healthcare$302.44-2.52%ClosedMarket Cap: $32.32B
As of 2026-05-26
Valuation
P/E (TTM)
113.15
PEG
0.78
P/B
10.75
P/S
6.46
EV/EBITDA
42.89
DCF Value
$-4,340.00
FCF Yield
3.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
87.2%
Operating Margin
12.0%
Net Margin
8.9%
ROE
12.1%
ROA
6.0%
ROIC
7.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.51B | 89.0% | $249.9M | $227.4M | $— | — |
| Q4 null | $1.50B | 90.5% | $185.0M | $66.5M | $— | — |
| FY null | $5.34B | 87.5% | $447.1M | $286.9M | $— | — |
| Q3 null | $1.41B | 86.1% | $163.1M | $124.8M | $— | — |
| Q2 null | $1.32B | 87.5% | $87.9M | $94.3M | $— | — |
| Q1 null | $1.12B | 85.2% | $11.1M | $1.3M | $— | — |
| Q4 null | $1.13B | 85.8% | $-79.4M | $-151.9M | $— | — |
| FY null | $3.81B | 84.4% | $-568.2M | $-644.8M | $— | — |
| Q3 null | $1.00B | 83.0% | $-120.3M | $-121.3M | $— | — |
| Q2 null | $929.2M | 85.1% | $-107.2M | $-120.4M | $— | — |
| Q1 null | $751.7M | 83.4% | $-261.3M | $-251.2M | $— | — |
| Q4 2023 | $634.4M | 83.3% | $-383.8M | $-367.6M | $-25.48 | — |